Owner Banyu Pharmaceutical Co., Ltd.

Inventors Sugimoto, Tetsuya; Masutani, Kouta; Hirai, Hiroshi; Kawanishi, Nobuhiko; Kamijyo, Kaori; Hirose, Masaaki; Shibata, Jun

Agent Griffith Hack

Pub. Number AU-B-2003275681

PCT Number PCT/JP03/13707

PCT Pub. Number WO2004/039809

Priority 2002-313588 29.10.02 JP

Filing date 27 October 2003

Wipo publication date 25 May 2004

Acceptance publication date 12 March 2009

C07D 487/18 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/4995 (2006.01) - Pyrazines or piperazines forming part of bridged ring systems

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/5377 (2006.01)

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 498/18 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 498/22 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 515/18 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

C07D 515/22 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or